GoodRx Holdings closed at $3.49 on Nov 3, down 1.69%, 8.2% below its 52-week closing high. Volume of 1.1M shares was 1.00× its 20-day average (close to normal).
Split-adjusted performance: +3.9% over one month, +36.3% over six months, +3.6% over one year.
In the quarter ended Jun 30, 2026, revenue was $200.41M, down 1.3% from a year earlier, with a net margin of 4.3%.
Short interest was 3.7M shares at the Oct 15 settlement, down 11.6% from the prior report (5.2% of float, 4.2 days to cover).